Evidence map›Paper›PMID 39803273›Full record

ReviewFood science & nutrition2025

Recent Perspectives on Anticancer Potential of Coumarin Against Different Human Malignancies: An Updated Review.

Muhammad Shahbaz, Asfa Perween, Ushna Momal, Muhammad Imran, Muhammad Hammad Ul Hassan, Hammad Naeem, Ahmed Mujtaba, Muzzamal Hussain, Suliman A Alsagaby, Waleed Al Abdulmonem and 5 more

Abstract readReview
In one paragraph

Review in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. A Substrate-Dependent Bifunctional Dioxygenase fromMolecules (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Muhammad ShahbazDepartment of Food Science and Technology Muhammad Nawaz Shareef University of Agriculture Multan Multan Pakistan.
Asfa PerweenDepartment of Human Nutrition and Dietetics Muhammad Nawaz Shareef University of Agriculture Multan Multan Pakistan.
Ushna MomalDepartment of Food Science and Technology Muhammad Nawaz Shareef University of Agriculture Multan Multan Pakistan.
Muhammad ImranDepartment of Food Science and Technology University of Narrowal Narrowal Pakistan.
Muhammad Hammad Ul HassanDepartment of Food Science and Technology Muhammad Nawaz Shareef University of Agriculture Multan Multan Pakistan.
Hammad NaeemDepartment of Food Science and Technology Muhammad Nawaz Shareef University of Agriculture Multan Multan Pakistan.
Ahmed MujtabaDepartment of Food Science and Technology, Faculty of Engineering Sciences and Technology Hamdard University Islamabad Campus Islamabad Pakistan.
Muzzamal HussainDepartment of Food Sciences Government College University Faisalabad Faisalabad Pakistan.ORCID https://orcid.org/0000-0001-6508-1962
Suliman A AlsagabyDepartment of Medical Laboratory Sciences, College of Applied Medical Sciences Majmaah University Al-Majmaah Saudi Arabia.
Waleed Al AbdulmonemDepartment of Pathology, College of Medicine Qassim University Buraidah Saudi Arabia.
Mohamed A AbdelgawadDepartment of Pharmaceutical Chemistry, College of Pharmacy Jouf University Sakaka Aljouf Saudi Arabia.
Ahmed H El-GhorabDepartment of Chemistry, College of Science Jouf University Sakaka Saudi Arabia.
Samy SelimDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences Jouf University Sakaka Saudi Arabia.ORCID https://orcid.org/0000-0003-4025-8586
Ehab M MostafaDepartment of Pharmacognosy, College of Pharmacy Jouf University Sakaka Saudi Arabia.
Entessar Al JbawiAgricultural Extension Directorate, MAAR Damascus Syria.ORCID https://orcid.org/0000-0002-1804-1770

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coumarins, a group of naturally occurring compounds, have been reported to demonstrate anticancer potential. These substances, distinguished by their combined benzene and α-pyrone rings, have been demonstrated to impact multiple cellular mechanisms essential for the initiation and advancement of cancer. These agents work in different ways that prevent different tumor cells from growing, spreading, and increasing. One of the main anticancer mechanisms of coumarin act is killing cancer cells through apoptosis. This includes changes to pro- and anti-apoptotic proteins like Bcl-2 and Bax, the release of cytochrome c from mitochondria, and the activation of caspases. The tumor suppressor protein p53's expression has been discovered to be upregulated by coumarins such as esculetin and imperatorin, which encourage interrupted cell cycle and death. Additionally, coumarin has anti-angiogenic qualities, which are critical for the development and spread of tumors. It can slow the development of new blood vessels that feed tumors by inhibiting the "vascular endothelial growth factor (VEGF)" route of signaling. Coumarins inhibit the number of signaling pathways that are vital for cell division. For example, they can suppress the "PI3K/mTOR" pathway, which usually impairs the cancer cells and results in decreased cell viability and growth. Finally, coumarins could modulate the response of the immune system to cancerous cells. They have the ability to boost the activity of natural killer cells and cytotoxic T lymphocytes, which aid the immune system in identifying and eliminating cancer cells. Through a variety of mechanisms, such as immune response regulation, angiogenesis reduction, cell growth inhibition, and apoptosis activation, coumarins exhibit their anticancer effects. These molecular pathways demonstrate coumarins' potential as an interesting option for the development of novel anticancer treatments. More studies are needed to completely understand their modes of action and maximize their therapeutic efficacy.

Indexed as

angiogenesisanti‐apoptotic proteinanticancer mechanismsapoptosisblood vesselsefficacyesculetinproliferationT lymphocytes

Identifiers

PMID39803273
PMCPMC11717051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.